
|Articles|May 1, 2004
Derms tackle patients' quality-of-life issues with need for rosacea-specific instrument
Washington - Investigators developing a rosacea-specific quality-of-life instrument (RosaQoL) have demonstrated its reliability and validity and have begun testing its responsiveness to changes in rosacea severity, said Suephy C. Chen, M.D., M.S., at the annual meeting of the American Academy of Dermatology.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging
3
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














